SXL
VXRT

Summit X LLC’s Vaxart VXRT Stock Holding History

Summit X LLC’s Portfolio VXRT Stock Details VXRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-26,400
Closed -$18K – 247
2019
Q2 		$18K Buy
+26,400
New +$22.1K 0.01% 232

Other funds holding VXRT

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Carlson Capital Management Northfield, Minnesota $2.29B AUM 7.48% 1-Year Est. Return

Summit X LLC's VXRT Position: Q3 2019 in Review

Summit X LLC sold out of Vaxart (VXRT) in Q3 2019, closing a stake of 26,400 shares — an estimated $18K sold.

Summit X LLC first reported a position in VXRT in Q2 2019 and held it in 1 quarter. The position peaked at $18K in Q2 2019. 22 funds tracked by Wall St. Rank hold VXRT as of Q3 2019.

  • Summit X LLC reported no remaining Vaxart position as of Q3 2019 after selling out during the quarter.
  • Summit X LLC sold 26,400 Vaxart shares in Q3 2019, an estimated $18K.
  • Summit X LLC first reported a position in Vaxart in Q2 2019 and held it in 1 quarter.
  • Summit X LLC's Vaxart position peaked at $18K in Q2 2019.
  • 22 funds tracked by Wall St. Rank held Vaxart as of Q3 2019.

Based on Summit X LLC's 13F filing for Q3 2019, filed 15 Oct 2019.